Opportunity Information: Apply for W81XWH 11 BCRP IDEA
Apply for W81XWH 11 BCRP IDEA
- The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Breast Cancer Idea Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
- This funding opportunity was created on Apr 19, 2011 and posted on Apr 19, 2011.
- Applicants must submit their applications by Aug 25, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $7,500,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 10 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The DoD Breast Cancer Research Program (BCRP) Idea Award (Funding Opportunity Number W81XWH-11-BCRP-IDEA) is a FY2011 discretionary funding opportunity from the Department of the Army, administered through USAMRAA, intended to push breast cancer research in bold directions that can open up new lines of investigation. The central purpose of the mechanism is to support promising, hypothesis-driven projects with an unusually strong chance of producing highly impactful data, even when the work carries more scientific risk than traditional incremental studies. The program is explicitly framed around accelerating major advances toward the eradication of breast cancer, so applicants are expected to make a clear case that their approach could change what is possible in the field rather than simply add another small piece of evidence.
This mechanism places the greatest emphasis on Impact and Innovation. Impact, in this context, means the project has credible potential to drive major advancements and meaningfully speed progress against breast cancer, such as enabling new prevention strategies, improving detection, transforming treatment approaches, or revealing important biological mechanisms that could redirect the field. Innovation refers to research that is conceptually original, such as introducing a new paradigm, challenging prevailing assumptions, reframing existing problems, or applying uniquely creative thinking or methods. Importantly, the solicitation notes that while innovation is highly valued, a proposal that is not especially innovative can still fit the award if it convincingly offers high potential impact. Regardless of where a project falls on the innovation spectrum, the Principal Investigator is responsible for explicitly explaining both the expected impact on breast cancer and what makes the work innovative (or, if not strongly innovative, why the likely impact is still extraordinary).
The funding opportunity allows preliminary data but does not require it, which signals openness to earlier-stage ideas as long as they are grounded in a strong scientific rationale and presented with a well-formulated, testable hypothesis. In other words, applicants do not need to have extensive pilot results in hand, but they do need to demonstrate that the proposed work is logically constructed, scientifically defensible, and designed to produce interpretable outcomes that can meaningfully move the field forward.
A notable feature is the Partnering PI Option, which is meant to encourage real, productive collaborations between two investigators. Under this structure, there are two PIs (an Initiating PI and a Partnering PI), and each PI is supported under a separate award, but both contribute to the development of a single, unified application. The intent is to bring together complementary strengths, whether from similar areas or very different disciplines, in a way that makes the combined effort more powerful than two parallel projects would be. Applicants using this option must clearly explain how the partnership improves the ability to answer the research question and why the work should be done together rather than split into separate efforts. New collaborations are welcomed but not mandatory. The announcement also clarifies a boundary for eligibility under this collaboration model: applications pairing a mentor and a postdoctoral trainee as the two PIs do not meet the intent of the Partnering PI Option.
From an administrative standpoint, this opportunity used grant and cooperative agreement funding instruments under the Science and Technology and other Research and Development activity category. The program anticipated about 10 awards with an estimated total funding level of $7.5 million, and it did not require cost sharing or matching. Eligibility is described as unrestricted (open to any type of entity), subject to any additional clarifications in the full text of the announcement. The opportunity was posted April 19, 2011, with an original and final closing date of August 25, 2011, and an archive date of September 24, 2011. The CFDA listing associated with the program is 12.420 (Military Medical Research and Development). For applicant support, the announcement provides contact points for program announcement access issues and for electronic submission help through the CDMRP help desk channels.
FAQs: DoD Breast Cancer Research Program (BCRP) Idea Award (FY2011) - W81XWH-11-BCRP-IDEA
What is this funding opportunity?
The DoD Breast Cancer Research Program (BCRP) Idea Award (Funding Opportunity Number W81XWH-11-BCRP-IDEA) is a FY2011 discretionary funding opportunity from the Department of the Army, administered through USAMRAA. It is designed to support breast cancer research ideas that push in bold directions and open up new lines of investigation.
What is the main purpose of the Idea Award mechanism?
The central purpose is to support promising, hypothesis-driven projects with an unusually strong chance of producing highly impactful data, even if the work involves more scientific risk than traditional incremental studies. The program is framed around accelerating major advances toward the eradication of breast cancer.
What kinds of projects are a strong fit for this award?
Projects are a strong fit when they make a credible case that they could change what is possible in the breast cancer field rather than simply add another small piece of evidence. The opportunity emphasizes research that can accelerate major progress against breast cancer.
What are the most important review priorities mentioned in the opportunity?
The mechanism places the greatest emphasis on Impact and Innovation. Applicants are expected to clearly address both, including explicit statements about expected impact on breast cancer and what makes the work innovative (or why the impact is extraordinary even if innovation is not the strongest aspect).
How is "Impact" described in this announcement?
Impact means the project has credible potential to drive major advancements and meaningfully speed progress against breast cancer. Examples of impactful directions include enabling new prevention strategies, improving detection, transforming treatment approaches, or revealing important biological mechanisms that could redirect the field.
How is "Innovation" described in this announcement?
Innovation refers to research that is conceptually original, such as introducing a new paradigm, challenging prevailing assumptions, reframing existing problems, or applying uniquely creative thinking or methods.
Can a project be funded if it is not highly innovative?
Yes. The solicitation notes that while innovation is highly valued, a proposal that is not especially innovative can still fit the award if it convincingly offers high potential impact. In that case, the applicant still needs to explain the expected impact and address innovation (including why extraordinary impact is still likely).
Does the opportunity require preliminary data?
No. Preliminary data are allowed but not required, signaling openness to earlier-stage ideas as long as they are grounded in a strong scientific rationale and presented with a well-formulated, testable hypothesis.
If preliminary data are not required, what does the program expect instead?
Applicants are expected to demonstrate that the proposed work is logically constructed, scientifically defensible, and designed to produce interpretable outcomes that can meaningfully move the field forward. A strong rationale and a testable hypothesis are emphasized.
What is the Partnering PI Option?
The Partnering PI Option is a feature meant to encourage real, productive collaborations between two investigators. Under this structure, there are two PIs (an Initiating PI and a Partnering PI) who contribute to a single, unified application.
How does funding work under the Partnering PI Option?
Each PI is supported under a separate award, but both awards support the development and execution of a single unified research application and effort.
What does the program expect applicants to explain when using the Partnering PI Option?
Applicants must clearly explain how the partnership improves the ability to answer the research question and why the work should be done together rather than split into separate efforts. The intent is that the collaboration produces something stronger than two parallel projects.
Are new collaborations required to use the Partnering PI Option?
No. New collaborations are welcomed but not mandatory.
Are there limits on what counts as an eligible partnership under the Partnering PI Option?
Yes. The announcement clarifies that applications pairing a mentor and a postdoctoral trainee as the two PIs do not meet the intent of the Partnering PI Option.
Who can apply (eligibility)?
Eligibility is described as unrestricted (open to any type of entity), subject to any additional clarifications in the full text of the announcement.
Is cost sharing or matching required?
No. The opportunity did not require cost sharing or matching.
How many awards were anticipated and what was the estimated total funding level?
The program anticipated about 10 awards with an estimated total funding level of $7.5 million.
What funding instruments and activity category are associated with this opportunity?
From an administrative standpoint, this opportunity used grant and cooperative agreement funding instruments under the Science and Technology and other Research and Development activity category.
What are the key dates for this opportunity?
The opportunity was posted on April 19, 2011. The original and final closing date was August 25, 2011. The archive date was September 24, 2011.
What is the CFDA number associated with this program?
The CFDA listing associated with the program is 12.420 (Military Medical Research and Development).
Where can applicants get help with access issues or electronic submission?
The announcement provides contact points for program announcement access issues and for electronic submission help through the CDMRP help desk channels.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: DoD Breast Cancer Transformative Vision Award
Previous opportunity: Community outreach plant program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 11 BCRP IDEA
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 11 BCRP IDEA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DoD Breast Cancer Transformative Vision Award Apply for W81XWH 11 BCRP TVA Funding Number: W81XWH 11 BCRP TVA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Defense Medical Research and Development Program Clinical Trial Award Regenerative Medicine, Pain, Sensory System Apply for W81XWH 12 DMRDP CTA RPS Funding Number: W81XWH 12 DMRDP CTA RPS Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Ovarian Cancer Translational Pilot Award Apply for W81XWH 11 OCRP TPA Funding Number: W81XWH 11 OCRP TPA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Ovarian Cancer Translational Leverage Award Apply for W81XWH 11 OCRP TLA Funding Number: W81XWH 11 OCRP TLA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Ovarian Cancer Teal Innovator Award Apply for W81XWH 11 OCRP TIA Funding Number: W81XWH 11 OCRP TIA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Ovarian Cancer Pilot Award Apply for W81XWH 11 OCRP PA Funding Number: W81XWH 11 OCRP PA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Plants Engineered To Replace Oil (PETRO) Apply for DE FOA 0000470 Funding Number: DE FOA 0000470 Agency: Headquarters Category: Science and Technology and other Research and Development Funding Amount: $15,000,000 |
| High Energy Advanced Thermal Storage (HEATS) Apply for DE FOA 0000471 Funding Number: DE FOA 0000471 Agency: Headquarters Category: Science and Technology and other Research and Development Funding Amount: $10,000,000 |
| Rare Earth Alternatives in Critical Technologies (REACT) Apply for DE FOA 0000472 Funding Number: DE FOA 0000472 Agency: Headquarters Category: Science and Technology and other Research and Development Funding Amount: $10,000,000 |
| Green Electricity Network Integration (GENI) Apply for DE FOA 0000473 Funding Number: DE FOA 0000473 Agency: Headquarters Category: Science and Technology and other Research and Development Funding Amount: $10,000,000 |
| Solar Agile Delivery of Electrical Power Technology (Solar ADEPT) Apply for DE FOA 0000474 Funding Number: DE FOA 0000474 Agency: Headquarters Category: Science and Technology and other Research and Development Funding Amount: $5,000,000 |
| DOD FY11 Prostate Cancer Physician Research Training Award Apply for W81XWH 11 PCRP PRTA Funding Number: W81XWH 11 PCRP PRTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Amyotrophic Lateral Sclerosis Therapeutic Idea Award Apply for W81XWH 11 ALSRP TIA Funding Number: W81XWH 11 ALSRP TIA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Amyotrophic Lateral Sclerosis Therapeutic Development Award Apply for W81XWH 11 ALSRP TDA Funding Number: W81XWH 11 ALSRP TDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DOD FY11 Prostate Cancer Postdoctoral Training Award Apply for W81XWH 11 PCRP PTA Funding Number: W81XWH 11 PCRP PTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD FY11 Prostate Cancer Health Disparity Training Award Apply for W81XWH 11 PCRP HDTA Funding Number: W81XWH 11 PCRP HDTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD FY11 Prostate Cancer Collaborative Undergraduate HBCU Student Summer Training Program Award Apply for W81XWH 11 PCRP STPA Funding Number: W81XWH 11 PCRP STPA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD FY11 Prostate Cancer Population Based Research Award Apply for W81XWH 11 PCRP PBRA Funding Number: W81XWH 11 PCRP PBRA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD FY11 Prostate Cancer Health Disparity Research Award Apply for W81XWH 11 PCRP HDRA Funding Number: W81XWH 11 PCRP HDRA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD FY11 Prostate Cancer Exploration Hypothesis Development Award Apply for W81XWH 11 PCRP EHDA Funding Number: W81XWH 11 PCRP EHDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 11 BCRP IDEA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
